My Items

Are you a student or a job seeker with a keen interest in the pharmaceutical industry, a sector known for its innovation and impact on global health? The pharmaceutical industry offers a multitude of opportunities for individuals looking to make a difference through their work. From developing life-saving medications to conducting cutting-edge research, working in this field can be immensely rewarding. Securing a job in the pharmaceutical industry is a competitive process that requires a strategic approach. It is essential to not only meet the eligibility criteria but also to showcase your passion for the industry and your willingness to learn and grow. By demonstrating a strong understanding of pharmaceutical concepts, staying updated on industry trends, and honing your interview skills, you can increase your chances of landing a position in a reputable pharmaceutical organization. Throughout this guide, we will delve into the key steps you need to take to position yourself as a strong candidate in the pharmaceutical job market. From crafting a compelling resume that highlights your relevant skills and experiences to preparing for behavioral and technical interviews, we will provide you with valuable insights and tips to help you navigate the recruitment process with confidence. Eligibility Criteria to Get a Job in Pharma Before diving into the application process, it's crucial to understand the eligibility criteria typically required to secure a job in the pharmaceutical sector. First and foremost, educational qualifications play a significant role in determining eligibility for pharmaceutical positions. Most pharmaceutical companies look for candidates with a background in pharmacy, chemistry, biology, or related fields. A bachelor's degree is often the minimum requirement, but many roles may require a master's or doctoral degree for more specialized positions. Aside from academic qualifications, relevant work experience is another crucial factor. Pharmaceutical companies often seek candidates with prior experience in the industry, whether through internships, co-op programs, or full-time employment. This experience not only demonstrates a candidate's understanding of the sector but also their ability to apply theoretical knowledge in practical settings. Furthermore, possessing certain skills and competencies can enhance an individual's eligibility for pharmaceutical roles. Strong analytical skills, attention to detail, problem-solving abilities, and a solid understanding of regulatory requirements are highly valued in this industry. Additionally, effective communication skills, both written and verbal, are essential for interacting with colleagues, clients, and regulatory bodies. Lastly, staying updated on industry trends, advancements in technology, and regulatory changes can give candidates a competitive edge in the pharmaceutical job market. Demonstrating a willingness to learn, adapt, and grow within the sector showcases a candidate's commitment to professional development and can make them a more attractive prospect to potential employers. Educational Qualifications : Most pharmaceutical organizations seek candidates with at least a bachelor's degree in pharmacy, chemistry, biology, or related fields. Higher qualifications like a master's or Ph.D. can provide a competitive edge. Technical Skills : Proficiency in areas such as research methodologies, data analysis, and laboratory techniques is highly valued in the pharmaceutical industry. Regulatory Knowledge : Familiarity with pharmaceutical regulations and quality control standards is essential for many roles. Interpersonal Skills : Effective communication, teamwork, and problem-solving abilities are key attributes that recruiters look for in prospective employees. Interview Preparation for a Job in Pharma When preparing for a job interview at a pharmaceutical organization, thorough preparation is key to standing out amongst other candidates. It is essential to research the company thoroughly, including its mission, values, and recent projects. Understanding the industry trends and challenges can also demonstrate your interest and commitment. Additionally, make sure to review your own qualifications and experiences that align with the specific requirements of the pharmaceutical role you are applying for. Highlighting your relevant skills, such as knowledge of drug development processes, regulatory compliance, or experience in clinical trials, can showcase your suitability for the position. Practice common interview questions related to the pharmaceutical industry, such as how you stay updated on new medications or how you handle ethical dilemmas in research. Being able to articulate your thoughts clearly and confidently can leave a lasting impression on the interviewers. Furthermore, pay attention to your attire and body language, aiming for a professional and confident demeanor. Arriving early, maintaining eye contact, and engaging in active listening during the interview can convey your enthusiasm and respect for the opportunity. In conclusion, by following these guidelines and investing time in thorough preparation, you can enhance your chances of excelling in a job interview at a pharmaceutical organization and securing the desired position. Research the Company : Familiarize yourself with the company's background, products, pipeline, and recent developments. This knowledge demonstrates your genuine interest in the organization. Understand the Role : Analyze the job description thoroughly to align your skills and experiences with the requirements of the position. Practice Common Interview Questions : Prepare responses to common pharmaceutical job interview questions, focusing on your strengths, experiences, and achievements. Showcase Your Knowledge : Be ready to discuss industry trends, challenges, and how you can contribute to the company's success. Professional Appearance : Dress smartly and maintain a professional demeanor during your interview. Ask Intelligent Questions : Prepare thoughtful questions to ask the interviewer about the role, team dynamics, and the company's future projects. Final Thoughts Securing a position in the pharmaceutical sector is an incredible achievement that opens the doors to a fulfilling career in a vital industry! By meeting the requirements, honing your interview skills, and demonstrating your passion for the field, you can greatly enhance your chances of landing that dream job. Remember, being prepared and maintaining a positive attitude are key to triumphing in your job search! Good luck with your job applications and interviews, and may you soon find yourself embarking on an exciting career in the pharmaceutical industry!

Ensuring the quality and integrity of products in the pharmaceutical industry is paramount, especially as advancements in research and development continue to push the boundaries of innovation. In the highly regulated environment of pharmaceuticals, any deviations, incidents, or out-of-specification results must be addressed with utmost diligence and precision. It is imperative to conduct a comprehensive investigation to not only rectify the immediate issue but also to prevent its recurrence in the future. One of the key methodologies employed in investigating such occurrences is the Fishbone Diagram, which is also known as the Ishikawa Diagram or Cause and Effect Diagram. This analytical tool is highly valued in the pharmaceutical sector for its ability to systematically identify and categorize potential root causes of a problem. By visually mapping out the various factors that could contribute to an issue, the Fishbone Diagram enables teams to delve deep into the complexities of the situation and uncover underlying causes that may not be immediately apparent. The Fishbone Diagram categorizes potential causes into different branches, such as equipment, process, people, materials, and environment, allowing investigators to explore all possible angles and variables that could have influenced the outcome. This structured approach not only helps in pinpointing the primary cause of the problem but also facilitates the development of effective corrective and preventive actions to address the issue at its core. Moreover, the utilization of the Fishbone Diagram promotes collaboration and cross-functional communication within pharmaceutical organizations. By involving stakeholders from various departments in the investigation process, a more holistic understanding of the problem can be achieved, leading to more robust and sustainable solutions. This collaborative effort not only strengthens the quality control processes but also fosters a culture of continuous improvement and proactive problem-solving within the pharmaceutical research and development landscape. Understanding Root Cause Analysis When faced with a deviation or incident in pharmaceutical manufacturing or testing, understanding the root cause is paramount for maintaining the integrity of the entire production process. Root cause analysis is a structured and systematic method that goes beyond surface-level fixes to identify the underlying reasons behind an issue. By delving deep into the contributing factors, organizations can uncover systemic weaknesses, process inefficiencies, or human errors that may have led to the problem. This comprehensive approach not only aids in resolving the immediate issue but also serves as a proactive measure to prevent similar incidents from occurring in the future. Furthermore, conducting a thorough root cause analysis is essential for ensuring compliance with stringent regulatory standards governing the pharmaceutical industry. By pinpointing the root cause of deviations, companies can implement targeted corrective actions that address the core issues, thereby enhancing overall quality control and regulatory adherence. This proactive stance not only mitigates risks associated with non-compliance but also fosters a culture of continuous improvement within the organization. In addition, the insights gained from root cause analysis can drive continuous process improvement initiatives within pharmaceutical manufacturing facilities. By identifying and rectifying underlying issues, companies can streamline operations, optimize workflows, and enhance overall efficiency. This proactive approach not only minimizes the likelihood of future deviations but also boosts productivity and competitiveness in the market. Fishbone Diagram: A Visual Tool for Root Cause Analysis The Fishbone Diagram, also known as the Ishikawa diagram or Cause and Effect diagram, is a structured approach used in quality management to identify and analyze the root causes of a problem. Its distinctive fishbone-like structure helps to visually represent the cause-and-effect relationships that contribute to a particular issue. By categorizing causes into groups such as equipment, process, people, environment, and materials, the diagram enables a thorough examination of all possible factors that could be influencing the outcome. In the context of pharmaceutical analyses, the Fishbone Diagram proves to be an invaluable tool for quality control and process improvement. It allows pharmaceutical professionals to systematically brainstorm and categorize the potential causes of deviations or out-of-specification results in their analytical processes. By providing a structured framework for investigation, the diagram helps teams to pinpoint the underlying issues that may be affecting the quality and reliability of their analytical data. Moreover, the Fishbone Diagram encourages cross-functional collaboration and communication within pharmaceutical organizations. By involving experts from different areas such as research and development, manufacturing, quality assurance, and regulatory affairs in the analysis process, the diagram promotes a holistic understanding of the problem and fosters collective problem-solving efforts. Overall, the Fishbone Diagram stands as a versatile and effective tool for problem-solving in pharmaceutical analyses, guiding teams towards identifying and addressing the root causes of issues to enhance the quality and integrity of their analytical results. Steps in Root Cause Identification Using a Fishbone Diagram Define the Problem: Clearly articulate the deviation, incident, or out-of-specification result that requires investigation. Identify Categories: Create branches for different categories of potential causes, linking them to the main problem. Brainstorm Causes: Engage a cross-functional team to brainstorm and identify potential causes within each category. Analyze Causes: Evaluate each cause for its relevance and impact on the identified problem. Determine Root Cause(s): Drill down to the root cause(s) by asking "Why?" repeatedly until reaching the underlying issue. Develop Corrective Actions: Once the root cause is pinpointed, develop and implement corrective actions to address the issue effectively. Cause and Effect Diagram for Comprehensive Analysis In addition to the Fishbone Diagram, pharmaceutical investigations can benefit from using the Cause and Effect Diagram, which visually demonstrates the relationship between various causes and their effects on the identified problem. This tool delves deeper into the cause-and-effect relationships, aiding in a comprehensive understanding of the factors influencing deviations or out-of-specification test results. Advantages of Root Cause Identification with Diagrams Structured Approach: Both the Fishbone and Cause and Effect Diagrams provide a structured method for analyzing complex issues systematically. Cross-Functional Collaboration: Involving a diverse team in brainstorming and analysis enhances the identification of potential causes and solutions. Visual Representation: Visual diagrams offer a clear representation of the relationships between causes and effects, aiding in effective communication and decision-making. Conclusion In the pharmaceutical industry, accurate root cause identification is fundamental to maintaining product quality, compliance, and patient safety. By employing tools like the Fishbone Diagram and Cause and Effect Diagram, organizations can streamline investigative processes, mitigate risks, and drive continuous improvement in their operations. Adopting a standardized approach to root cause analysis ensures that deviations and out-of-specification results are addressed comprehensively, leading to enhanced quality control practices and regulatory compliance. Next time you encounter a deviation or out-of-specification test result in pharmaceutical analysis, consider leveraging the power of visual tools like the Fishbone Diagram and Cause and Effect Analysis for a robust root cause identification process. Remember, a proactive approach to investigation today ensures a smoother path to successful quality assurance tomorrow.

In the fast-paced world of pharmaceuticals, accuracy and precision are paramount. The use of statistical tools plays a crucial role in ensuring the quality and efficacy of pharmaceutical products. From control charts to process capability factors, these tools empower professionals to make data-driven decisions and maintain the highest standards. Let's dive into the top 10 statistical tools that every pharmaceutical employee should be familiar with: 1. Control Charts Control charts are a fundamental tool in pharmaceutical analysis, allowing professionals to monitor processes over time and detect any variations that may occur. By graphically displaying data points, control charts enable quick identification of trends or anomalies that could impact product quality. 2. Standard Deviation Standard deviation is a key statistical measure that helps pharmaceutical professionals understand the dispersion of data points within a dataset. By calculating the standard deviation, individuals can assess the consistency and variability of results, aiding in decision-making processes. 3. Process Capability Factor (Cpk) The process capability factor, often denoted as Cpk, is an essential metric in pharmaceutical analysis that quantifies a process's ability to produce products within specified limits. By calculating Cpk values, professionals can evaluate process performance and ensure that it meets quality standards. 4. Histograms Histograms are graphical representations of data distribution, providing pharmaceutical employees with a visual depiction of frequency and intensity. Analyzing histograms aids in identifying patterns and trends within datasets, facilitating informed decisions in product development and quality control. 5. Scatter Plots Scatter plots are valuable tools for visualizing relationships between variables in pharmaceutical analysis. By plotting data points on a graph, professionals can identify correlations or patterns that may exist, leading to insights that drive research and development efforts. 6. Pareto Analysis Pareto analysis is a prioritization technique that helps pharmaceutical professionals identify the most significant factors contributing to a particular outcome. By focusing on the vital few rather than the trivial many, Pareto analysis streamlines decision-making processes and enhances efficiency in pharmaceutical operations. 7. Box Plots Box plots, also known as box-and-whisker plots, offer a concise way to represent data distribution and variability. In pharmaceutical analysis, box plots provide a visual summary of key statistical measures, such as median, quartiles, and outliers, aiding in the interpretation of complex datasets. 8. ANOVA (Analysis of Variance) ANOVA is a statistical technique used in pharmaceutical research to compare means across two or more groups. By conducting ANOVA tests, professionals can determine whether differences observed in data are statistically significant, guiding experimental design and data interpretation. 9. Regression Analysis Regression analysis is a powerful tool for modeling relationships between variables in pharmaceutical studies. By examining the impact of independent variables on a dependent variable, regression analysis helps predict outcomes and optimize processes to enhance drug development and manufacturing. 10. Chi-Square Test The Chi-Square test is a statistical method used to assess the independence of categorical variables in pharmaceutical analysis. By evaluating the association between variables, pharmaceutical professionals can make informed decisions regarding treatment efficacy, patient outcomes, and product safety. In conclusion, mastering these essential statistical tools is vital for pharmaceutical professionals to analyze data accurately, make informed decisions, and ensure the quality and safety of pharmaceutical products. By leveraging these tools effectively, professionals can drive advancements in drug development, regulatory compliance, and patient care, shaping the future of the pharmaceutical industry. Become a statistical expert and elevate your pharmaceutical analysis with these indispensable tools!

In the dynamic landscape of pharmaceutical laboratories, accuracy and precision are paramount. Human error, albeit inevitable, can be a major stumbling block that jeopardizes the integrity and reliability of laboratory analyses. To maintain the highest standards of quality and safety in pharmaceutical manufacturing, it is imperative to implement strategies that mitigate the risks associated with human error. Let's delve into some key approaches that can significantly reduce the incidence of human error in pharmaceutical laboratories and analyses, safeguarding the efficacy and trustworthiness of the industry's products. Understanding the Root Causes of Human Error Before delving into strategies to minimize human error, it is crucial to understand the underlying factors contributing to its occurrence. Human error in pharmaceutical laboratories can stem from various sources, including fatigue, distraction, inadequate training, poor communication, and lack of standard operating procedures. Identifying these root causes is the first step towards developing effective preventive measures. Implementing Robust Training Programs Investing in comprehensive training programs is key to ensuring that laboratory personnel are well-equipped to perform their tasks accurately and proficiently. Ongoing training not only enhances technical skills but also fosters a culture of continuous learning and improvement. By emphasizing the importance of attention to detail, adherence to protocols, and critical thinking, organizations can empower their staff to consistently deliver high-quality results. Standardizing Procedures and Documentation Standard operating procedures (SOPs) play a pivotal role in minimizing human error by providing clear guidelines for conducting experiments, analyses, and other laboratory activities. By standardizing procedures and documenting every step of the process, laboratories can reduce variability, enhance reproducibility, and mitigate the risk of errors caused by misinterpretation or oversight. Regular reviews and updates of SOPs are essential to ensure compliance with the latest protocols and best practices. Leveraging Automation and Technology The integration of automation and technology in pharmaceutical laboratories can significantly enhance efficiency and accuracy while reducing the likelihood of human error. Automated systems for data collection, sample preparation, and analysis not only streamline processes but also minimize manual intervention, thereby mitigating errors associated with human factors. By embracing cutting-edge technologies, laboratories can elevate their capabilities and elevate the quality of their outputs. Cultivating a Culture of Quality and Accountability Creating a culture of quality and accountability is instrumental in fostering a mindset of precision and excellence among laboratory personnel. By promoting transparency, open communication, and a strong sense of responsibility, organizations can instill a culture where every team member takes ownership of their actions and strives for perfection in every task. Recognizing and rewarding individuals who demonstrate a commitment to quality can further reinforce this culture and drive continuous improvement. Conclusion In conclusion, the quest to minimize human error in pharmaceutical laboratories and analyses requires a multifaceted approach that addresses the root causes of errors while leveraging training, standardization, technology, and a culture of quality. By implementing these strategies proactively, pharmaceutical manufacturers can enhance the reliability, precision, and safety of their products, ultimately benefiting both patients and the industry as a whole. By prioritizing accuracy and quality in every aspect of laboratory operations, organizations can uphold the highest standards of excellence and integrity in the pursuit of scientific advancement.

In the pharmaceutical industry, root cause analysis is a crucial procedure used to pinpoint and resolve fundamental issues that affect product quality, safety, and compliance. The 5 WHY analysis stands out as a highly efficient tool for carrying out this type of analysis. It entails repeatedly asking "why" to explore the underlying causes of a problem until the core issue is revealed. How to Conduct a 5 WHY Analysis Step 1: Define the Problem Before diving into the analysis, it's crucial to clearly define the problem you are trying to solve. Whether it's a deviation in a manufacturing process, a quality issue in a product, or a safety concern, a well-defined problem statement will guide the analysis. Step 2: Formulate the First "Why" Once the problem is defined, ask the question "why" to identify the immediate cause of the issue. For example, if the problem is a batch failure, the first "why" could be "Why did the batch fail?" Step 3: Repeat the Process With the first "why" identified, continue the analysis by asking "why" again to uncover the cause of the cause. Repeat this process iteratively, aiming for a minimum of five "whys" to dig deep into the root cause. Step 4: Analyze the Findings As you uncover each "why," document the insights gained to trace the problem back to its origin. Analyze the collected information to understand the interconnected factors contributing to the issue. Step 5: Identify the Root Cause By the time you reach the fifth "why," you should have identified the root cause of the problem. This fundamental issue, when addressed, can prevent the recurrence of similar problems in the future. Gaining Insights with a 5 WHY Analysis Understanding the Complexity The pharmaceutical industry is multifaceted, involving intricate processes and stringent regulations. A 5 WHY analysis helps unravel the complexities within these processes to pinpoint the underlying causes of deviations or failures. Driving Continuous Improvement Implementing a 5 WHY analysis culture in pharmaceutical organizations fosters a mindset of continuous improvement. By consistently applying this method, teams can proactively address issues before they escalate, leading to enhanced product quality and compliance. Enhancing Problem-Solving Skills Engaging in a 5 WHY analysis sharpens problem-solving skills within pharmaceutical teams. It encourages a systematic approach to root cause identification, nurturing a culture of critical thinking and data-driven decision-making. Conclusion In the pharmaceutical industry, where product quality and patient safety are paramount, uncovering the root cause of issues is essential. By employing a 5 WHY analysis, organizations can go beyond addressing surface-level problems and tackle underlying issues effectively. Embracing this method as a standard practice can transform the way pharmaceutical companies approach problem-solving and continuous improvement.

In the pharmaceutical industry, maintaining Good Manufacturing Practices (GMP) compliance is vital to ensure the safety, quality, and efficacy of pharmaceutical products. Pharmaceutical manufacturers adhere to strict guidelines to meet regulatory standards and guarantee the integrity of their operations. Let's delve into the key steps that pharmaceutical companies follow to ensure GMP compliance effectively. Step 1: Understand GMP Requirements GMP regulations outline the standards for the design, monitoring, and control of manufacturing processes and facilities. Pharmaceutical manufacturers must have a thorough understanding of these requirements to ensure compliance from the production line to distribution. Step 2: Establish Quality Systems Implementing robust quality management systems is essential for maintaining GMP compliance. These systems cover procedures for document control, deviations, corrective and preventive actions (CAPA), and change control to uphold quality standards. Step 3: Conduct Risk Assessment Identifying and mitigating potential risks in manufacturing processes is crucial for GMP compliance. Risk assessments help in proactively addressing vulnerabilities and ensuring consistent product quality. Step 4: Train Employees Training programs are key to fostering a culture of compliance within pharmaceutical companies. Employees need to be informed about GMP regulations and equipped with the necessary skills to perform their roles effectively. Step 5: Audit Internal Processes Regular internal audits help companies evaluate their GMP compliance status. By conducting audits, manufacturers can identify areas for improvement and implement corrective measures promptly. Step 6: Implement Corrective Actions In cases where deviations from GMP standards are identified, prompt corrective actions must be taken to rectify the issues and prevent recurrence. This proactive approach is vital for maintaining compliance. Step 7: Monitor Supplier Compliance Ensuring that suppliers and vendors also adhere to GMP standards is essential for maintaining a compliant supply chain. Pharmaceutical companies must evaluate and monitor their suppliers to uphold quality throughout the manufacturing process. Step 8: Prepare for Regulatory Inspections Being prepared for regulatory inspections is crucial in the pharmaceutical industry. Companies should maintain comprehensive documentation, data integrity, and transparency to demonstrate their commitment to GMP compliance during inspections. Step 9: Continuous Improvement Continuous evaluation of processes and systems is necessary for driving improvements and maintaining GMP compliance. By seeking opportunities for enhancement, pharmaceutical manufacturers can adapt to changing regulations and industry best practices. Step 10: Stay Informed Staying up-to-date with regulatory changes and industry trends is essential for ensuring ongoing GMP compliance. Continuous learning and engagement with industry updates help pharmaceutical companies adapt their practices to meet evolving requirements. By following these ten steps rigorously, pharmaceutical companies can enhance their GMP compliance efforts, uphold quality standards, and prioritize patient safety throughout the drug production process. Remember, in the pharmaceutical industry, adherence to GMP regulations is not just a requirement – it's a commitment to delivering safe and effective products to consumers worldwide.

First Read Photostability Testing of New Drug Substances and Products First Read Photostability Testing of New Drug Substances Photostability Testing of New Drug Products: Normally, the studies on drug products should be carried out in a sequential manner starting with testing the fully exposed product then progressing as necessary to the product in the immediate pack and then in the marketing pack. Testing should progress until the results demonstrate that the drug product is adequately protected from exposure to light. The drug product should be exposed to the light conditions described under the Procedure , Normally, only one batch of drug product is tested during the development phase, and then the photostability characteristics should be confirmed on a single batch if the product is clearly photostable or photolabile. If the results of the confirmatory study are equivocal, testing of up to two additional batches should be conducted. For some products where it has been demonstrated that the immediate pack is completely impenetrable to light, such as aluminium tubes or cans, testing should normally only be conducted on directly exposed drug product. It may be appropriate to test certain products such as infusion liquids, dermal creams, etc., to support their photostability in-use. The extent of this testing should depend on and relate to the directions for use, and is left to the applicant’s discretion. The analytical procedures used should be suitably validated. Presentation of Samples Care should be taken to ensure that the physical characteristics of the samples under test are taken into account and efforts, such as cooling and/or placing the samples in sealed containers, should be made to ensure that the effects of the changes in physical states are minimized, such as sublimation, evaporation, or melting. All such precautions should be chosen to provide a minimal interference with the irradiation of samples under test. Possible interactions between the samples and any material used for containers or for general protection of the sample should also be considered and eliminated wherever not relevant to the test being carried out. Where practicable when testing samples of the drug product outside of the primary pack, these should be presented in a way similar to the conditions mentioned for the drug substance. The samples should be positioned to provide maximum area of exposure to the light source. For example, tablets, capsules, etc., should be spread in a single layer. If direct exposure is not practical (e.g., due to oxidation of a product), the sample should be placed in a suitable protective inert transparent container (e.g., quartz). If testing of the drug product in the immediate container or as marketed is needed, the samples should be placed horizontally or transversely with respect to the light source, whichever provides for the most uniform exposure of the samples. Some adjustment of testing conditions may have to be made when testing large volume containers (e.g., dispensing packs). Analysis of Samples At the end of the exposure period, the samples should be examined for any changes in physical properties (e.g., appearance, clarity or color of solution, dissolution/disintegration for dosage forms such as capsules, etc.) and for assay and degradants by a method suitably validated for products likely to arise from photochemical degradation processes. When powder samples are involved, sampling should ensure that a representative portion is used in individual tests. For solid oral dosage form products, testing should be conducted on an appropriately sized composite of, for example, 20 tablets or capsules. Similar sampling considerations, such as homogenization or solubilization of the entire sample, apply to other materials that may not be homogeneous after exposure (e.g., creams, ointments, suspensions, etc.). The analysis of the exposed sample should be performed concomitantly with that of any protected samples used as dark controls if these are used in the test. Judgment of Results Depending on the extent of change special labeling or packaging may be needed to mitigate exposure to light. When evaluating the results of photostability studies to determine whether change due to exposure to light is acceptable, it is important to consider the results obtained from other formal stability studies in order to assure that the product will be within proposed specifications during the shelf life (see the relevant ICH Stability and Impurity Guidelines).

First Read Photostability Testing of New Drug Substances and Products PHOTOSTABILITY OF DRUG SUBSTANCE: For drug substances, photostability testing should consist of two parts: forced degradation testing and confirmatory testing. The purpose of forced degradation testing studies is to evaluate the overall photosensitivity of the material for method development purposes and/or degradation pathway elucidation. This testing may involve the drug substance alone and/or in simple solutions/suspensions to validate the analytical procedures. In these studies, the samples should be in chemically inert and transparent containers. In these forced degradation studies, a variety of exposure conditions may be used, depending on the photosensitivity of the drug substance involved and the intensity of the light sources used. For development and validation purposes it is appropriate to limit exposure and end the studies if extensive decomposition occurs. For photostable materials, studies may be terminated after an appropriate exposure level has been used. The design of these experiments is left to the applicant’s discretion although the exposure levels used should be justified. Under forcing conditions, decomposition products may be observed that are unlikely to be formed under the conditions used for confirmatory studies. This information may be useful in developing and validating suitable analytical methods. If in practice it has been demonstrated they are not formed in the confirmatory studies, these degradation products need not be further examined. Confirmatory studies should then be undertaken to provide the information necessary for handling, packaging, and labeling (see section Procedure , and Presentation , for information on the design of these studies). Normally, only one batch of drug substance is tested during the development phase, and then the photostability characteristics should be confirmed on a single batch selected as described in the Parent Guideline if the drug is clearly photostable or photolabile. If the results of the confirmatory study are equivocal, testing of up to two additional batches should be conducted. Samples should be selec ted as described in the Parent Guideline. Presentation of Samples Care should be taken to ensure that the physical characteristics of the samples under test are taken into account and efforts should be made, such as cooling and/or placing the samples in sealed containers, to ensure that the effects of the changes in physical states such as sublimation, evaporation or melting are minimized. All such precautions should be chosen to provide minimal interference with the exposure of samples under test. Possible interactions between the samples and any material used for containers or for general protection of the sample should also be considered and eliminated wherever not relevant to the test being carried out. As a direct challenge for samples of solid drug substances, an appropriate amount of sample should be taken and placed in a suitable glass or plastic dish and protected with a suitable transparent cover if considered necessary. Solid drug substances should be spread across the container to give a thickness of typically not more than 3 millimeters. Drug substances that are liquids should be exposed in chemically inert and transparent containers. Analysis of Samples At the end of the exposure period, the samples should be examined for any changes in physical properties (e.g., appearance, clarity, or color of solution) and for assay and degradants by a method suitably validated for products likely to arise from photochemical degradation processes. Where solid drug substance samples are involved, sampling should ensure that a representative portion is used in individual tests. Similar sampling considerations, such as homogenization of the entire sample, apply to other materials that may not be homogeneous after exposure. The analysis of the exposed sample should be performed concomitantly with that of any protected samples used as dark controls if these are used in the test. Judgment of Results The forced degradation studies should be designed to provide suitable information to develop and validate test methods for the confirmatory studies. These test methods should be capable of resolving and detecting photolytic degradants that appear during the confirmatory studies. When evaluating the results of these studies, it is important to recognize that they form part of the stress testing and are not therefore designed to establish qualitative or quantitative limits for change. The confirmatory studies should identify precautionary measures needed in manufacturing or in formulation of the drug product, and if light-resistant packaging is needed. When evaluating the results of confirmatory studies to determine whether change due to exposure to light is acceptable, it is important to consider the results from other formal Stability studies in order to assure that the drug will be within justified limits at the time of use (see the relevant ICH Stability and Impurity Guidelines) Photostability for Drug Product (Next Article)

Photostability Testing of New Drug Substances and Products: The intrinsic photostability characteristics of new drug substances and products should be evaluated to demonstrate that, as appropriate, light exposure does not result in unacceptable change. Normally, photostability testing is carried out on a single batch of material. ( Selection of Batches ) Under some circumstances, these studies should be repeated if certain variations and changes are made to the product (e.g., formulation, packaging). Whether these studies should be repeated depends on the photostability characteristics determined at the time of initial filing and the type of variation and/or change made. The guideline primarily addresses the generation of photostability information for submission in Registration Applications for new molecular entities and associated drug products. The guideline does not cover the photostability of drugs after administration (i.e. under conditions of use) and those applications not covered by the Parent Guideline. Alternative approaches may be used if they are scientifically sound and justification is provided. A systematic approach to photostability testing is recommended covering, as appropriate, studies such as: i) Tests on the drug substance; ii) Tests on the exposed drug product outside of the immediate pack; and if necessary ; iii) Tests on the drug product in the immediate pack; and if necessary ; iv) Tests on the drug product in the marketing pack. The extent of drug product testing should be established by assessing whether or not acceptable change has occurred at the end of the light exposure testing as described in the Decision Flow Chart for Photostability Testing of Drug Products. Acceptable change is change within limits justified by the applicant. The formal labeling requirements for photolabile drug substances and drug products are established by national/regional requirements. Light Sources The light sources described below may be used for photostability testing. The applicant should either maintain an appropriate control of temperature to minimize the effect of localized temperature changes or include a dark control in the same environment unless otherwise justified. For both options 1 and 2, a pharmaceutical manufacturer/applicant may rely on the spectral distribution specification of the light source manufacturer. Option 1 Any light source that is designed to produce an output similar to the D65/ID65 emission standard such as an artificial daylight fluorescent lamp combining visible and ultraviolet (UV) outputs, xenon, or metal halide lamp. D65 is the internationally recognized standard for outdoor daylight as defined in ISO 10977 (1993). ID65 is the equivalent indoor indirect daylight standard. For a light source emitting significant radiation below 320 nm, an appropriate filter(s) may be fitted to eliminate such radiation. Option 2 For option 2 the same sample should be exposed to both the cool white fluorescent and near ultraviolet lamp. 1. A cool white fluorescent lamp designed to produce an output similar to that specified in ISO 10977(1993); and 2. A near UV fluorescent lamp having a spectral distribution from 320 nm to 400 nm with a maximum energy emission between 350 nm and 370 nm; a significant proportion of UV should be in both bands of 320 to 360 nm and 360 to 400 nm. Procedure For confirmatory studies, samples should be exposed to light providing an overall illumination of not less than 1.2 million lux hours and an integrated near ultraviolet energy of not less than 200-watt hours/square meter to allow direct comparisons to be made between the drug substance and drug product. Samples may be exposed side-by-side with a validated chemical actinometric system to ensure the specified light exposure is obtained, or for the appropriate duration of time when conditions have been monitored using calibrated radiometers/lux meters. An example of an actinometric procedure is provided in the Annex. If protected samples (e.g., wrapped in aluminum foil) are used as dark controls to evaluate the contribution of thermally induced change to the total observed change, these should be placed alongside the authentic sample. Annex Quinine Chemical Actinometry The following provides details of an actinometric procedure for monitoring exposure to a near UV fluorescent lamp (based on FDA/National Institute of Standards and Technology study). For other light sources/actinometric systems, the same approach may be used, but each actinometric system should be calibrated for the light source used. Prepare a sufficient quantity of a 2 percent weight/volume aqueous solution of quinine monohydrochloride dihydrate (if necessary, dissolve by heating). Option 1 Put 10 milliliters (ml) of the solution into a 20 ml colorless ampoule seal it hermetically, and use this as the sample. Separately, put 10 ml of the solution into a 20 ml colourless ampoule (see note 1), seal it hermetically, wrap in aluminum foil to protect completely from light, and use this as the control. Expose the sample and control to the light source for an appropriate number of hours. After exposure determine the absorbances of the sample (AT) and the control (Ao) at 400 nm using a 1 centimeter (cm) path length. Calculate the change in absorbance,  A = AT - Ao. The length of exposure should be sufficient to ensure a change in absorbance of at least 0.9. Option 2 Fill a 1 cm quartz cell and use this as the sample. Separately fill a 1 cm quartz cell, wrap in aluminum foil to protect completely from light, and use this as the control. Expose the sample and control to the light source for an appropriate number of hours. After exposure determine the absorbances of the sample (AT) and the control (Ao) at 400 nm. Calculate the change in absorbance,  A = AT - Ao. The length of exposure should be sufficient to ensure a change in absorbance of at least 0.5. Alternative packaging configurations may be used if appropriately validated. Alternative validated chemical actinometers may be used. Note 1: Shape and Dimensions (See Japanese Industry Standard (JIS) R3512 (1974) for ampoule specifications) Photostability for Drug Substance (Next Article) Photostability for Drug Product (Next Article) Reference: ICH Guideline Q1B

The list of titles of the Code of Federal Regulations The 21 CFR is the Titel 21 for Food and Drugs

Hetero Drugs Ltd. Job Opening for GENERAL MANAGER QUALITY CONTROL Department: Quality Control Experience: 20 to 25 years Location: Nakkapalli Qualification: M.Sc Chemistry Job Description
General Manager QC:
General Manager - Quality Control responsible to oversee the operations of Quality Control functions of Active Pharmaceutical Ingredients(API).
Managing all administrative and technical issues of Quality control Review of analytical results. Ensuring the preventive maintenance and calibration reports as per the schedule Ensuring Good laboratory practices and Laboratory safety standards Responsible for Review of analytical data (worksheet and backup data) received from various sections of QC laboratory Responsible for overall monitoring of Quality Control system Must have exposure of stability management and analytical method validation along with routine commercial and exhibit batch analysis. Responsible for leading operations of QC and ensuring the quality control processes, Review and analysing the results, and offer expertise views. Verify all processes are complying to established specifications, protocols and established quality standards. Ability to represent and lead Audits as front runner Draft, Review, revise and verification of quality standards and Analytical reports and instruct to record and report quality data. Investigate and handle customer complaints of QC and perform root cause anlysis Ensure the team audit readiness and periodical review of performance of quality control systems to ensure efficiency. Ensuring the regulatory compliance of QC as applicable with Comprehensive knowledge of quality control systems, procedures, protocols, standards and regulatory requirements. Should have experience in handling of Regulatory Inspections and the queries and handling of Audits & Regulatory compliance Thorough knowledge of method transfer, method development, technology transfer documents, Qualification and validations Corrective and Preventive actions to address the probabilities of re-occurrences and to fix them Expert in analytical Investigations leading QC team of 200 members , People management skills Developing procedures Periodical review of expenses and budgetary controls Handling of Non-conforming results I.e OOS/OOT - Quality Control - handling out of specification/Out of trends investigations Adhering to the respective standard operating procedures/protocols. Review QMS documents e.g. Change control/Deviation/Incidents-Discrepancy if any To perform periodic and audit trail review of computerized systems in laboratory To support the initiatives undertaken by corporate quality for further strengthening of process, leading change management processes Approve SOPs, Guidelines/Policies as applicable. Guide and mentor QC teams To assess the existing facility and inventories v/s future requirement and offer proposals subsequently Good communication skills and people management with decision making skills, Sound knowledge on QC operations and compliance and thorough knowledge of CSV process
(Preferred Candidate from USFDA approved pharmaceutical API facility ) 20 + years of Experience, At least 15 years experience in Managerial role (Must have the experience in leading of Quality Control in regulatory approved facility only) Email ID talent@heterodrugs.com dharma.ch@hetero.com

Intas Pharmaceuticals, SEZ Ahmedabad Job opening for Quality Assurance - QMS Position SR.OFFICER – SR.EXECUTIVE Experience – 4 –9 Years Education – B.PHARMA / M.PHARMACY Employment Type : Full Time, Permanent Department QUALITY ASSURANCE - QMS Job Location - Ahmedabad (Gujarat) CHANGODAR. Note : candidates should apply resume with mentioned subject code: . OOS / OOT 10, CRF 10, Deviation - 10 Job Description Handling of QMS related activities like change request form, Market complaint, Deviation, CAPA and investigation. Co-ordination and handling of QMS activities in software, monitoring and closing of action plans within the timeline and effectiveness evaluation. Handling and co-ordination of deviation and to perform the investigation/ Risk Assessment and assigning of CAPA. To perform the investigation triggered from Market complaint, ADE, Deviation, Out of Specification (OOS), OOT (Out of Trend), Out of Calibration etc. in software. Preparation of market complaint/ADE, deviations, change request and CAPA review summery. To prepare and co-ordinate investigation study and execution of protocol. & Co-ordination for Quality Review Steering Committee and handling of CAPA initiation from the outcome. Co-ordination for Self Inspection activity i.e. preparation of schedule, Audit planning, Audit Report and Compliance and CAPA. To perform the risk assessment related to process, facility, equipment etc. in co-ordination with cross-functional team members. To review the executed BPCRs and other related documents in relation to deviation, investigation and market complaints. Kindly send your updated resume on meghal_desai@intaspharma.com and jobs@pharmaceuticalguideline.com Meghal Desai Human Resources Intas Pharmaceuticals Limited